PeriAPPAC-T: The Prevalence of Appendiceal Tumours in Periappendicular Abscess

Sponsor
Turku University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04634448
Collaborator
Oulu University Hospital (Other), Tampere University Hospital (Other), Kuopio University Hospital (Other), Jyväskylä Central Hospital (Other), Mikkeli Central Hospital (Other), Lapland Central Hospital (Other), Vaasa Central Hospital, Vaasa, Finland (Other), Seinajoki Central Hospital (Other), North Karelia Central Hospital (Other), South Carelia Central Hospital (Other), Päijänne Tavastia Central Hospital (Other), Satakunta Central Hospital (Other)
400
2
181

Study Details

Study Description

Brief Summary

Complicated and uncomplicated appendicitis follow different epidemiological trends also suggesting different pathophysiology behind these two different forms of appendicitis. In 3-10% of patients complicated acute appendicitis is enclosed by formation of a circumscribed periappendicular abscess. The clinically established practice of antibiotic therapy and drainage, if necessary, has been shown safe and effective, allowing the acute inflammatory process to subside in more than 90% of cases without surgery. The need of subsequent interval appendectomy has been questioned with appendicitis recurrence risk varying between 5-26%.

During trial enrollment in our randomized Peri-APPAC trial based on the interim analysis results with 17% appendiceal tumor rate in the study population, the trial was prematurely terminated based on ethical concerns. All the follow-up group patients were re-evaluated and surgery was offered and recommended to all follow-up group patients. After this assessment and additional appendectomies, two more tumors were diagnosed resulting in neoplasm rate of 20% in the whole study group all diagnosed in patients over 40 years and the neoplasm rate in patients over 40 years was 29%.

Based on high appendiceal tumor rate in patients over 40 years, the appendiceal neoplasm rate needs to be further evaluated in prospective patient cohorts undergoing interval appendectomy as interval appendectomy is generally well tolerated and obliterates the risk of missing a possible tumor. In a recent systematic review of retrospective cohort studies with 13.244 acute appendicitis patients the overall appendiceal tumor rate was 1% after appendectomy, but in patients presenting with appendiceal inflammatory mass the neoplasm rate varied from 10% to 29%.

This nationwide prospective multicenter cohort study is designed to assess the prevalence of appendiceal tumors associated with a periappendicular abscess. All consecutive patients presenting with a periappendicular abscess are recommended to undergo interval appendectomy after initial conservative treatment with antibiotic therapy and drainage, if necessary. All patients older than 35 years will undergo laparoscopic interval appendectomy at 2 to 3 months and this is also recommended for the patients between 18 and 35 years of age. Asymptomatic patients under 35 years not willing to undergo interval appendectomy, will undergo a follow-up MRI at 1 year after the initial non-operative treatment.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Interval appendectomy
  • Diagnostic Test: Follow-up MRI at 1 year
N/A

Detailed Description

Complicated and uncomplicated appendicitis follow different epidemiological trends also suggesting different pathophysiology behind these two different forms of appendicitis. In 3-10% of patients complicated acute appendicitis is enclosed by formation of a circumscribed periappendicular abscess. The clinically established practice of antibiotic therapy and drainage, if necessary, has been shown safe and effective, allowing the acute inflammatory process to subside in more than 90% of cases without surgery. The need of subsequent interval appendectomy has been questioned with appendicitis recurrence risk varying between 5-26%.

During trial enrollment in our randomized Peri-APPAC trial, the high incidence of appendiceal tumors in the study population alarmed the researchers. Based on the interim analysis results with 17% appendiceal tumor rate in the study population, the trial was prematurely terminated based on ethical concerns. All the follow-up group patients were re-evaluated and surgery was offered and recommended to all follow-up group patients. After this assessment and additional appendectomies, two more tumors were diagnosed resulting in neoplasm rate of 20% in the whole study group all diagnosed in patients over 40 years and the neoplasm rate in patients over 40 years was 29%.

Based on high appendiceal tumor rate in patients over 40 years, the appendiceal neoplasm rate needs to be further evaluated in prospective patient cohorts undergoing interval appendectomy as interval appendectomy is generally well tolerated and obliterates the risk of missing a possible tumor. In a recent systematic review of retrospective cohort studies with 13.244 acute appendicitis patients the overall appendiceal tumor rate was 1% after appendectomy, but in patients presenting with appendiceal inflammatory mass the neoplasm rate varied from 10% to 29%.

This nationwide prospective multicenter cohort study is designed to assess the prevalence of appendiceal tumors associated with a periappendicular abscess. All of the study hospitals will have a common clinical protocol of recommending interval appendectomy to all patients presenting with a periappendicular abscess after initial conservative treatment with antibiotic therapy and drainage, if necessary. Considering the high rate of appendiceal neoplasms, all patients older than 35 years will undergo laparoscopic interval appendectomy at 2 to 3 months after the successful initial non-operative treatment and this is also recommended for the patients between 18 and 35 years of age. Asymptomatic patients under 35 years not willing to undergo interval appendectomy, will undergo a follow-up MRI at 1 year after the initial non-operative treatment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective clinical cohort studyProspective clinical cohort study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Prevalence of Appendiceal Tumours in Patients Presenting With a Periappendicular Abscess - A Nationwide Prospective Cohort Study
Anticipated Study Start Date :
Dec 1, 2020
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2035

Arms and Interventions

Arm Intervention/Treatment
Other: Interval appendectomy

For all patients presenting with a periappendicular abscess, an interval appendectomy is planned at 2 to 3 months after initial conservative treatment, which is considered mandatory for all patients over 35 years of age. If a patient is under 35 and asymptomatic and does not want to undergo surgery, a follow-up MRI at 1 year will be performed.

Procedure: Interval appendectomy
interval appendectomy at 2 to 3 months after the initial non-operative treatment

Other: Follow-up MRI

For all patients presenting with a periappendicular abscess, an interval appendectomy is planned at 2 to 3 months after initial conservative treatment, which is considered mandatory for all patients over 35 years of age. If a patient is under 35 and asymptomatic and does not want to undergo surgery, a follow-up MRI at 1 year will be performed.

Diagnostic Test: Follow-up MRI at 1 year
follow-up MRI at 1 year for asymptomatic patients under 35 years of age not wanting to undergo surgery

Outcome Measures

Primary Outcome Measures

  1. The Prevalence of Appendiceal Tumours in Periappendicular Abscess [2-3 months (interval appendectomy)]

    The Prevalence of Appendiceal Tumours in Patients Presenting With a Periappendicular Abscess - A Nationwide Prospective Cohort Study

Secondary Outcome Measures

  1. Tympanic temperature [Day 0 (on primary admission)]

    All patients

  2. Imaging (primary diagnosis) finding [Day 0 (on primary admission)]

    All patients

  3. Duration of symptoms on admission [Day 0 (on primary admission)]

    All patients

  4. Laboratory value: CRP [Day 0 (on primary admission) up to 3-5 days (discharge from the hospital)]

    CRP

  5. Laboratory value: leuckocytes [Day 0 (on primary admission) up to 3-5 days (discharge from the hospital)]

    leuk

  6. Laboratory value: neutrophils [Day 0 (on primary admission) up to 3-5 days (discharge from the hospital)]

    neutr

  7. Laboratory value: hemoglobin [Day 0 (on primary admission) up to 3-5 days (discharge from the hospital)]

    Hb

  8. Laboratory value: kreatinine [Day 0 (on primary admission) up to 3-5 days (discharge from the hospital)]

    Krea

  9. Laboratory value: CEA [Day 0 (on primary admission) up to 3-5 days (discharge from the hospital) and up to 1 year, if no interval appendectomy]

    CEA

  10. Laboratory value. Cg-A [Day 0 (on primary admission) up to 3-5 days (discharge from the hospital)and up to 1 year, if no interval appendectomy]

    Cg-A

  11. Primary nonoperative treatment [Day 0 and up to one week]

    All patients, treatment details

  12. Colonoscopy: endoscopic findings and histology [2 weeks to 2 months prior to planned interval appendectomy]

    In both intervention groups

  13. Interval appendectomy specimen histology [At 3 months]

    Interval appendectomy patients

  14. Complications after interval appendectomy [at the time of surgery]

    Clavien-Dindo classification, interval appendectomy group

  15. Duration of hospital stay [up to 2 years]

    All patients both at primary treatment, interval appendectomy and follow-up

  16. Follow-up MRI findings [at 1 year]

    In case the patient does not under interval appendectomy

  17. follow-up CEA [at 1 year]

    Follow-up MRI patients

  18. follow-up CgA [at 1 year]

    Follow-up MRI patients

  19. Surgery after follow-up MRI [up to 10 years]

    Follow-up with MRI patients

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • periappendiceal abscess proven by CT, Mri or US
Exclusion Criteria:
  • patient declines to participate, complicated appendicitis without periappendiceal abscess

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Turku University Hospital
  • Oulu University Hospital
  • Tampere University Hospital
  • Kuopio University Hospital
  • Jyväskylä Central Hospital
  • Mikkeli Central Hospital
  • Lapland Central Hospital
  • Vaasa Central Hospital, Vaasa, Finland
  • Seinajoki Central Hospital
  • North Karelia Central Hospital
  • South Carelia Central Hospital
  • Päijänne Tavastia Central Hospital
  • Satakunta Central Hospital

Investigators

  • Principal Investigator: Paulina Salminen, prof, MD, Turku University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Paulina Salminen, Professor of Surgery, Turku University Hospital
ClinicalTrials.gov Identifier:
NCT04634448
Other Study ID Numbers:
  • PeriAPPAC-T
First Posted:
Nov 18, 2020
Last Update Posted:
Nov 18, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2020